塞法胺-阿维巴克坦诱导的脏疾病:过去和现在
Yanrong Shi1, Jichao Wu2, Wei Mi1
1Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Frontiers in pharmacology
|February 6, 2024
概括
塞法胺-阿维巴克坦 (CAZ-AVI) 对抗性细菌有效,但在现实环境中可能会更频繁地导致急性损伤 (AKI). 接受其他毒药物的重症患者面临更高的风险.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 抗菌素耐药性,特别是来自多药耐药格拉姆阴性病原体的抗菌性,构成了全球重大健康挑战.
- 塞法胺-阿维巴克坦 (CAZ-AVI) 在体外对产生卡巴酶的生物有强烈的活性,使其成为复杂感染的关键治疗方法.
- 虽然临床试验表明CAZ-AVI的罕见急性损伤 (AKI),但实际数据表明发生率更高,特别是在特定的患者群体中.
研究的目的:
- 审查有关CAZ-AVI和功能障碍的安全数据.
- 讨论功能障碍患者中CAZ-AVI的药理动力学/药理动力学目标和剂量调整.
- 突出CAZ-AVI相关AKI的临床意义,并为患有功能障碍的重症患者提供剂量优化的指导.
主要方法:
- 关于CAZ-AVI和功能障碍的现有安全数据的全面审查.
- 对功能相关的药理动力学/药理动力学性质的分析.
- 讨论关于CAZ-AVI相关的AKI的临床试验和现实世界的证据.
主要成果:
- CAZ-AVI通常耐受良好,但实际研究表明,与临床试验相比,AKI的发生频率更高.
- 同时使用毒剂和严重疾病被确定为CAZ-AVI相关AKI的风险因素.
- 为了在患有功能障碍的患者中有效和安全地使用CAZ-AVI,需要考虑特定的药理动力学/药理动力学因素.
结论:
- 医疗保健专业人员必须警CAZ-AVI相关AKI在现实临床实践中的潜力.
- 对患有功能障碍的重症患者来说,剂量优化至关重要,以减轻AKI风险.
- 需要进一步的研究和临床监测,以完善CAZ-AVI在脆弱患者群体的剂量策略.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
01:11Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
131
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
131
01:28Renal Drug Excretion: Tubular Secretion
185
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
185
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
229
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
229
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431